✦ LIBER ✦

Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a gynecologic oncology group study

✍ Scribed by Sarah Lincoln M.D.; John A Blessing Ph.D.; Roger B Lee M.D.; Thomas F Rocereto M.D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of oxaliplatin as second-

✍ Paula M. Fracasso; John A. Blessing; Kelly L. Molpus; Lisa M. Adler; Joel I. Sor 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 115 KB

A phase II evaluation of flavopiridol as

✍ Edward C. Grendys Jr.; John A. Blessing; Robert Burger; James Hoffman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Cisplatin as second-line therapy in ovar

✍ J.Tate Thigpen; John A Blessing; George Olt; Samuel S Lentz; Jeffrey Bell 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Phase II trial of cisplatin as first-lin

✍ Jt Thigpen; JA Blessing; H Homesley; WT Creasman; G Sutton 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Phase II trial of clsplatin as first-lin

✍ J.Tate Thigpen; John A. Blessing; Howard Homesley; William T. Creasman; Gregory 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Phase II trial of gemcitabine as second-

✍ Katherine Y Look; Alan Sandler; John A Blessing; Joseph A Lucci III; Peter G Ros 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB